Effectiveness of Zometa® treatment for the prevention of bone metastases in high risk prostate cancer patients - ZEUS

Trial Profile

Effectiveness of Zometa® treatment for the prevention of bone metastases in high risk prostate cancer patients - ZEUS

Completed
Phase of Trial: Phase III

Latest Information Update: 30 Jun 2017

At a glance

  • Drugs Zoledronic acid (Primary) ; Calcium; Vitamin D
  • Indications Bone metastases
  • Focus Therapeutic Use
  • Acronyms ZEUS
  • Most Recent Events

    • 15 Sep 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top